Abstract
Alopecia areata (AA) is an immune-mediated non-scarring hair loss disorder associated with a predominant TH1cytokine profile.1 The risk of individuals with AA contracting COVID-19 is of concern to physicians as well as the entire community affected by AA. We performed a large-retrospective cohort study to determine the risk of contracting COVID-19 in individuals with AA compared to individuals without AA. We queried the Symphony Health-derived data from the COVID-19 Research Database,2 and individuals with a diagnosis of AA were identified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
